These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 26514408)

  • 1. Handgrip weakness and mortality risk in COPD: a multicentre analysis.
    Burtin C; Ter Riet G; Puhan MA; Waschki B; Garcia-Aymerich J; Pinto-Plata V; Celli B; Watz H; Spruit MA
    Thorax; 2016 Jan; 71(1):86-7. PubMed ID: 26514408
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial.
    Sillen MJ; Franssen FM; Delbressine JM; Vaes AW; Wouters EF; Spruit MA
    Thorax; 2014 Jun; 69(6):525-31. PubMed ID: 24399630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk.
    Lee CT; Wang PH
    BMC Pulm Med; 2021 Jul; 21(1):245. PubMed ID: 34289815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global muscle dysfunction as a risk factor of readmission to hospital due to COPD exacerbations.
    Vilaró J; Ramirez-Sarmiento A; Martínez-Llorens JM; Mendoza T; Alvarez M; Sánchez-Cayado N; Vega A; Gimeno E; Coronell C; Gea J; Roca J; Orozco-Levi M
    Respir Med; 2010 Dec; 104(12):1896-902. PubMed ID: 20541383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients.
    Cortopassi F; Divo M; Pinto-Plata V; Celli B
    Respir Med; 2011 May; 105(5):748-54. PubMed ID: 21251806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease.
    Ansari K; Keaney N; Taylor I; Burns G; Farrow M
    Postgrad Med J; 2012 Jul; 88(1041):372-6. PubMed ID: 22388793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring muscle strength for people with chronic obstructive pulmonary disease: retest reliability of hand-held dynamometry.
    O'Shea SD; Taylor NF; Paratz JD
    Arch Phys Med Rehabil; 2007 Jan; 88(1):32-6. PubMed ID: 17207672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal relationship between handgrip strength and cognitive performance in oldest old people.
    Taekema DG; Ling CH; Kurrle SE; Cameron ID; Meskers CG; Blauw GJ; Westendorp RG; de Craen AJ; Maier AB
    Age Ageing; 2012 Jul; 41(4):506-12. PubMed ID: 22374646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link?
    Sin DD; Man SF
    Thorax; 2006 Jan; 61(1):1-3. PubMed ID: 16396949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is inflammation good, bad or irrelevant for skeletal muscles in COPD?
    Sin DD; Reid WD
    Thorax; 2008 Feb; 63(2):95-6. PubMed ID: 18234651
    [No Abstract]   [Full Text] [Related]  

  • 11. Verifying the hypothesis of overwork weakness in Charcot-Marie-Tooth.
    Videler AJ; Beelen A; Nollet F
    J Rehabil Med; 2010 Apr; 42(4):380; author reply 380-1. PubMed ID: 20461343
    [No Abstract]   [Full Text] [Related]  

  • 12. Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications.
    Qaisar R; Karim A; Muhammad T; Alkahtani SA; Kamli H; Ahmad F
    Respir Med; 2023; 215():107298. PubMed ID: 37245649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease.
    Van Vliet M; Spruit MA; Verleden G; Kasran A; Van Herck E; Pitta F; Bouillon R; Decramer M
    Am J Respir Crit Care Med; 2005 Nov; 172(9):1105-11. PubMed ID: 16100014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measuring the handgrip strength of geriatric patients].
    Kerckhofs AG; Vandewoude MF; Mudde AN
    Tijdschr Gerontol Geriatr; 2014 Sep; 45(4):197-207. PubMed ID: 24827615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral muscle weakness in RASopathies.
    Stevenson DA; Allen S; Tidyman WE; Carey JC; Viskochil DH; Stevens A; Hanson H; Sheng X; Thompson BA; Okumura MJ; Reinker K; Johnson B; Rauen KA
    Muscle Nerve; 2012 Sep; 46(3):394-9. PubMed ID: 22907230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [COPD: not just the airway matters].
    Rodríguez González-Moro JM; de Lucas Ramos P
    Med Clin (Barc); 2004 Apr; 122(14):535-6. PubMed ID: 15117646
    [No Abstract]   [Full Text] [Related]  

  • 17. A new two-tier strength assessment approach to the diagnosis of weakness in intensive care: an observational study.
    Parry SM; Berney S; Granger CL; Dunlop DL; Murphy L; El-Ansary D; Koopman R; Denehy L
    Crit Care; 2015 Feb; 19(1):52. PubMed ID: 25882719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle contractility is preserved in COPD patients with normal fat-free mass.
    Degens H; Sanchez Horneros JM; Heijdra YF; Dekhuijzen PN; Hopman MT
    Acta Physiol Scand; 2005 Jul; 184(3):235-42. PubMed ID: 15954991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral muscle weakness in COPD: where does it come from?
    Polkey MI
    Thorax; 2003 Sep; 58(9):741-2. PubMed ID: 12947126
    [No Abstract]   [Full Text] [Related]  

  • 20. Walking abnormalities are associated with COPD: An investigation of the NHANES III dataset.
    Yentes JM; Sayles H; Meza J; Mannino DM; Rennard SI; Stergiou N
    Respir Med; 2011 Jan; 105(1):80-7. PubMed ID: 20615681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.